Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies... Read more
Elcelyx is a developer of novel and re-positioning therapies for clinical developmental studies... Read more
News
May 29, 2019
Business Wire
Press Release: Elcelyx Therapeutics : Anji Pharmaceuticals Acquires Late-Stage Clinical Asset and Readies for Ph3 Trials in Type 2 Diabetes with Chronic Kidney Disease
Oct 06, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jul 31, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 20, 2018
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250
Aug 02, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27072017 Prices from USD $250
Apr 05, 2017
BioPortfolio
Elcelyx Therapeutics: Elcelyx Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 16032017 Prices from USD $250
Nov 14, 2016
Drug Development Technology
Elcelyx Therapeutics:
Elcelyx Therapeutics reports positive Phase IIb study results of Metformin DR to treat type 2 diabetes
Nov 11, 2016
PharmaLeaders
Elcelyx Therapeutics: Elcelyx unveils positive results in phase 2b study of Metformin DR in type 2 diabetes
Oct 12, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Elects To Board Of Directors
May 25, 2016
BioSpace
Elcelyx Therapeutics: Elcelyx Therapeutics Completes Enrollment In Phase 2b Clinical Trial Of Metformin Delayed Release For Type 2 Diabetes
Elcelyx Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10